Linda Morinello discusses the benefits and teaches you simple mindfulness methods that you can incorporate.

If you have Waldenstrom’s Macroglobulinemia (WM) or you are a caregiver of a patient with WM, you can help by completing our surveys.

Lymphoma Canada is preparing submissions to the pan­Canadian Oncology Drug Review (pCODR) for: Ibrutinib (Imbruvica) for patients with previously untreated CLL for whom fludarabine-based treatment is considered inappropriate and Venetoclax (ABT-199) for patients with relapsed/refractory CLL

Health Canada has issued a Notice of Compliance (NOC) for ibrutinib (Imbruvica®), a promising oral therapy, for the treatment of patients with Waldenström's macr

If you have Hodgkin lymphoma and have been treated with brentuximab vedotin (Adcetris) or are a caregiver of an individual with Hodgkin lymphoma, you can help by completing our survey.

Follicular Lymphoma Patients and Caregivers: Thank You!

2016 - 2018 Research Fellowship

Lymphoma Canada is now accepting applications for the Research Fellowship award.  

On January 23rd, the Cumberland Bandits rallied together to organize a fundraiser for Estephanie.